LouisMarshallSloanMD

PubMed

• Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a...
  Pedro Cahn, Richard Kaplan, Paul E. Sax, Kathleen Squires, Jean-Michel Molina, Anchalee Avihingsanon, Winai Ratanasuwan, Evelyn Rojas, Mohammed Rassool, Mark Bloch, Li...> ;The Lancet HIV. 2017 Nov 1
• Inflammatory Biomarker Changes and Their Correlation with Framingham Cardiovascular Risk and Lipid Changes in Antiretroviral-Naive HIV-Infected Patients Treated for 14...
  Benjamin Young, Kathleen Squires, Lisa L. Ross, Lizette Santiago, Louis Sloan, Henry H. Zhao, Brian Wine, Gary E. Pakes, David A. Margolis, Mark S. Shaefer> ;AIDS Research and Human Retroviruses. 2012 Oct 8
• Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of dolutegravir as 10-day monotherapy in HIV-1-infected adults.
  Sherene Min, Louis Sloan, Edwin DeJesus, Trevor Hawkins, Lewis McCurdy, Ivy Song, Richard Stroder, Shuguang Chen, Mark R. Underwood, Tamio Fujiwara, Stephen C. Piscite...> ;AIDS. 2011 Sep 10
• Central nervous system tuberculosis.
  Kuo, V.C., Sloan, L.M., Emmett, M.> ;Proc (Bayl Univ Medical Ctr). 2010 Oct
• Short communication: Comparable safety and efficacy with once-daily versus twice-daily dosing of lopinavir/ritonavir tablets with emtricitabine + tenofovir DF in antir...
  Juan González-García, Daniel E. Cohen, Margaret A. Johnson, Louis Sloan, Linda M. Fredrick, Christian Naylor, Barbara A. da Silva, Bernstein Barry M> ;AIDS Research and Human Retroviruses. 2010 Aug 12
• Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment.
  Kimberly Y. Smith, Parul Patel, Derek M. Fine, Nicholaos C. Bellos, Louis Sloan, Philip Lackey, Princy Kumar, Denise H Sutherland-Phillips, Cindy Vavro, Linda Yau, Pau...> ;AIDS. 2009 Jul 31
• Simplification of antiretroviral therapy to a single-tablet regimen consisting of efavirenz, emtricitabine, and tenofovir disoproxil fumarate versus unmodified antiret...
  Edwin DeJesus, Benjamin Young, Javier O Morales-Ramirez, Louis Sloan, Douglas J. Ward, John F. Flaherty, Ramin Ebrahimi, Jen-Fue Maa, Karen Reilly, Janet Ecker, Damian...> ;Journal of Acquired Immune Deficiency Syndromes. 2009 Jun 1
• Primary effusion lymphoma diagnosed by pericardiocentesis.
  Nemunaitis, M.C., Schussler, J.M., Shiller, S.M., Sloan, L.M., Mennel, R.G.> ;Proc (Bayl Univ Medical Ctr). 2009-01-01
• Antiviral activity and safety of aplaviroc with lamivudine/zidovudine in HIV-infected, therapy-naive patients: the ASCENT (CCR102881) study.
  Currier, J., Lazzarin, A., Sloan, L., Clumeck, N., Slims, J., McCarty, D., Steel, H., Kleim, J. P., Bonny, T., Millard, J.> ;Antivir Ther (Lond). 2008
• Patients experiencing early virologic failure on a protease inhibitor- or nonnucleoside reverse transcriptase inhibitor-based initial regimen containing a thymidine an...
  Rodriguez, A., Hill-Zabala, C., Sloan, L., Jefferson, T., Yau, L., Watson, M., Irlbeck, D., Shaefer, M.> ;J Acquir Immune Defic Syndr. 2006 Jan 1
• Comparison of once-daily fosamprenavir boosted with either 100 or 200 mg of ritonavir, in combination with abacavir/lamivudine: 96-week results from COL100758.
  Hicks, C. B., DeJesus, E., Sloan, L. M., Sension, M. G., Wohl, D. A., Liao, Q., Ross, L. L., Pakes, G. E., Pappa, K. A., Lancaster, C. T.> ;AIDS Res Hum Retroviruses. 2009 Apr
• Join now to see all